Article
16 Sep 2026
Qui Tam Lives To Fight Another Day: What The Eleventh Circuit’s Zafirov Decision Means For The False Claims Act
CONTRIBUTING SINCE MARCH 2011
Buchanan Ingersoll & Rooney PC
With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
POPULAR TOPICS
Food, Drugs, Healthcare, Life Sciences
International Law
Employment and HR
Technology
Cannabis & Hemp
Buchanan Ingersoll & Rooney PC are most popular:
- within Insurance, Government and Public Sector topic(s)
- with readers working within the Healthcare industries
DETAILS
United States
+1 412 562 8800
Union Trust Building
501 Grant Street
Suite 200
Pittsburgh
United States
Contact Firm
COMPANY CONTENT
Article
16 Sep 2026
Pharmacy Marketing And The Anti-Kickback Statute: Where To Draw The Line
Article
15 Sep 2026
Deadline Approaching: Proposed Changes To Remote Patient Monitoring (RPM) – Act Now
Article
13 Sep 2026
Pharmacy Succession Planning: Navigating Change Of Ownership, Medicare, Medicaid And PBM Requirements
Article
11 Sep 2026
Alternative Power Plays: Inside The World Of Competitive Wholesale Power With EPSA’s Todd Snitchler – Part 2 (Podcast)
Article
07 Sep 2026
NYC’s High-Value Property Tax: An In-Depth Look At The Pied-à-Terre Levy And Its Challenges
Article
06 Sep 2026
Tenth Circuit Stays Nationwide Eligibility Injunction For Class Of 2022 In Wisne v. NCAA
Article
04 Sep 2026
Restoring DMEPOS Medicare Billing Privileges: Challenging Revocations, Reactivation Dates And Enrollment Determinations
Article
01 Sep 2026
VIP Products, LLC v. Jack Daniel’s Properties, Inc.: Ninth Circuit Vacates Injunction In Parody Trademark Dispute
Article
01 Sep 2026
FDA Seeks Input On How To Regulate Generative AI-Enabled Medical Devices To Shape Upcoming Guidance
Article
27 Aug 2026
Pennsylvania Superior Court Affirms Overturned $19 Million Corporate Negligence Jury Verdict Against Nursing Home Management Entities
Article
25 Aug 2026
Alternative Power Plays: Inside The World Of Competitive Wholesale Power With EPSA’s Todd Snitchler – Part 1 (Podcast)
Article
25 Aug 2026
FDA Advisory Committee Voted Yes On Six Peptides. Now What? The Regulatory Road Ahead
Article
20 Aug 2026
Ohio Board of Pharmacy Proposes Expansion of Technology-Enabled Pharmacy Practice
Article
20 Aug 2026
DOJ Announces National Fraud Enforcement Division Priorities And Enhanced Authority In Bid To “Supercharge” Fraud Enforcement
Article
20 Aug 2026
Nevada’s Proposed Pharmacy Staffing Rules Raise A Broader Question: How Should Boards Regulate Workload And Patient Safety?
Article
19 Aug 2026
HRSA Revives The 340B Rebate Pilot: Covered Entities Should Prepare Now For 2027
Article
19 Aug 2026
Analyzing The Evolution And Misapplication Of Binger v. King Pest Control (1981): Implications For Civil Discovery And Trial Management
Article
18 Aug 2026
NCAA Enjoined From Enforcing New Fifth-Year Eligibility Rule
Article
17 Aug 2026
FDA Extends DSCSA Exemption For Small Pharmacies Through November 27, 2027: What Pharmacies Need To Know
AWARDS
